The therapeutic potential of apelin in kidney disease

FA Chapman, D Nyimanu, JJ Maguire… - Nature Reviews …, 2021 - nature.com
Chronic kidney disease (CKD) is a leading cause of global morbidity and mortality and is
independently associated with cardiovascular disease. The mainstay of treatment for CKD is …

[HTML][HTML] ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among …

SG Ramos, BA da Cruz Rattis, G Ottaviani… - The American journal of …, 2021 - Elsevier
Abstract SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the etiological
agent of COVID-19 (coronavirus disease 2019) and the cause of the current pandemic …

Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists

AA de Oliveira, A Vergara, X Wang, JC Vederas… - Peptides, 2022 - Elsevier
The apelin/apelin receptor (ApelinR) signal transduction pathway exerts essential biological
roles, particularly in the cardiovascular system. Disturbances in the apelin/ApelinR axis are …

Safety and outcomes associated with the pharmacological inhibition of the kinin–kallikrein system in severe COVID-19

E Mansour, AC Palma, RG Ulaf, LC Ribeiro… - Viruses, 2021 - mdpi.com
Background: Coronavirus disease 19 (COVID-19) can develop into a severe respiratory
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …

SARS-CoV-2 receptor is co-expressed with elements of the kinin–kallikrein, renin–angiotensin and coagulation systems in alveolar cells

D Sidarta-Oliveira, CP Jara, AJ Ferruzzi, MS Skaf… - Scientific reports, 2020 - nature.com
Abstract SARS-CoV-2, the pathogenic agent of COVID-19, employs angiotensin converting
enzyme-2 (ACE2) as its cell entry receptor. Clinical data reveal that in severe COVID-19 …

The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders

E Marsault, C Llorens‐Cortes, X Iturrioz… - Annals of the New …, 2019 - Wiley Online Library
The apelinergic pathway has been generating increasing interest in the past few years for its
potential as a therapeutic target in several conditions associated with the cardiovascular and …

Lipid-based nanotechnology: Liposome

Y Jiang, W Li, Z Wang, J Lu - Pharmaceutics, 2023 - mdpi.com
Over the past several decades, liposomes have been extensively developed and used for
various clinical applications such as in pharmaceutical, cosmetic, and dietetic fields, due to …

Apelin and vasopressin: the yin and yang of water balance

PE Girault-Sotias, R Gerbier, A Flahault… - Frontiers in …, 2021 - frontiersin.org
Apelin, a (neuro) vasoactive peptide, plays a prominent role in controlling body fluid
homeostasis and cardiovascular functions. Experimental data performed in rodents have …

Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications

P Chatterjee, M Gheblawi, K Wang, J Vu… - Clinical …, 2020 - portlandpress.com
The apelinergic system is widely expressed and acts through autocrine and paracrine
signaling to exert protective effects, including vasodilatory, metabolic, and inotropic effects …

Elabela inhibits TRAF1/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing

Y Hong, J Li, Y Zhong, S Yang, L Pei, Z Huang, X Chen… - Iscience, 2023 - cell.com
Diabetic foot ulcer (DFU) is a serious complication of diabetes. Elabela (ELA), a ligand of
apelin receptor (APJ), was shown to promote angiogenesis and suppress inflammation. This …